359 related articles for article (PubMed ID: 32557276)
1. Factors Associated with Diabetes Control in Predominately African American and Hispanic Population with Newly Diagnosed Type 2 Diabetes.
Morkos M; Tahsin B; Fogelfeld L
J Racial Ethn Health Disparities; 2021 Apr; 8(2):332-338. PubMed ID: 32557276
[TBL] [Abstract][Full Text] [Related]
2. Characterization of type 2 diabetes mellitus burden by age and ethnic groups based on a nationwide survey.
Lopez JM; Bailey RA; Rupnow MF; Annunziata K
Clin Ther; 2014 Apr; 36(4):494-506. PubMed ID: 24508418
[TBL] [Abstract][Full Text] [Related]
3. Impact of diabetes control on mortality by race in a national cohort of veterans.
Hunt KJ; Gebregziabher M; Lynch CP; Echols C; Mauldin PD; Egede LE
Ann Epidemiol; 2013 Feb; 23(2):74-9. PubMed ID: 23238350
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes.
Egede LE; Mueller M; Echols CL; Gebregziabher M
Med Care; 2010 Jun; 48(6):527-33. PubMed ID: 20473215
[TBL] [Abstract][Full Text] [Related]
5. Glycemic control and self-rated health among ethnically diverse adolescents with type 1 diabetes.
Kane NS; Hoogendoorn CJ; Commissariat PV; Schulder TE; Gonzalez JS
Pediatr Diabetes; 2020 Feb; 21(1):69-76. PubMed ID: 31589350
[TBL] [Abstract][Full Text] [Related]
6. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
7. Patient adherence improves glycemic control.
Rhee MK; Slocum W; Ziemer DC; Culler SD; Cook CB; El-Kebbi IM; Gallina DL; Barnes C; Phillips LS
Diabetes Educ; 2005; 31(2):240-50. PubMed ID: 15797853
[TBL] [Abstract][Full Text] [Related]
8. Racial and ethnic differences in glycemic control of adults with type 2 diabetes.
Harris MI; Eastman RC; Cowie CC; Flegal KM; Eberhardt MS
Diabetes Care; 1999 Mar; 22(3):403-8. PubMed ID: 10097918
[TBL] [Abstract][Full Text] [Related]
9. Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.
McAdam-Marx C; Bellows BK; Unni S; Wygant G; Mukherjee J; Ye X; Brixner DI
J Manag Care Spec Pharm; 2014 Jul; 20(7):691-700. PubMed ID: 24967522
[TBL] [Abstract][Full Text] [Related]
10. Racial and ethnic differences in uncontrolled diabetes mellitus among adults taking antidiabetic medication.
Berg KA; Bharmal N; Tereshchenko LG; Le P; Payne JY; Misra-Hebert AD; Rothberg MB
Prim Care Diabetes; 2024 Jun; 18(3):368-373. PubMed ID: 38423828
[TBL] [Abstract][Full Text] [Related]
11. Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes.
Egede LE; Lynch CP; Gebregziabher M; Hunt KJ; Echols C; Gilbert GE; Mauldin PD
J Gen Intern Med; 2013 Feb; 28(2):208-15. PubMed ID: 22948932
[TBL] [Abstract][Full Text] [Related]
12. Retrospective Study on the Impact of Adherence in Achieving Glycemic Goals in Type 2 Diabetes Mellitus Patients Receiving Canagliflozin.
Buysman EK; Anderson A; Bacchus S; Ingham M
Adv Ther; 2017 Apr; 34(4):937-953. PubMed ID: 28251556
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period.
Mansour AA; Alibrahim NTY; Alidrisi HA; Alhamza AH; Almomin AM; Zaboon IA; Kadhim MB; Hussein RN; Nwayyir HA; Mohammed AG; Al-Waeli DKJ; Hussein IH;
Diabetes Metab Syndr; 2020; 14(3):265-272. PubMed ID: 32272433
[TBL] [Abstract][Full Text] [Related]
14. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
[TBL] [Abstract][Full Text] [Related]
15. Distinct trajectories of HbA
Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
[TBL] [Abstract][Full Text] [Related]
16. The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study.
Elliott T; Beca S; Beharry R; Tsoukas MA; Zarruk A; Abitbol A
Diab Vasc Dis Res; 2021; 18(4):14791641211021374. PubMed ID: 34275385
[TBL] [Abstract][Full Text] [Related]
17. Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management program.
Philis-Tsimikas A; Zhang Q; Walker C
Am J Ther; 2006; 13(6):466-72. PubMed ID: 17122525
[TBL] [Abstract][Full Text] [Related]
18. Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes: Empowerment Perceptions and Diabetes Distress as Important Determinants.
Chen SY; Hsu HC; Wang RH; Lee YJ; Hsieh CH
Biol Res Nurs; 2019 Mar; 21(2):182-189. PubMed ID: 30585081
[TBL] [Abstract][Full Text] [Related]
19. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
[TBL] [Abstract][Full Text] [Related]
20. Comparison of community health worker-led diabetes medication decision-making support for low-income Latino and African American adults with diabetes using e-health tools versus print materials: a randomized, controlled trial.
Heisler M; Choi H; Palmisano G; Mase R; Richardson C; Fagerlin A; Montori VM; Spencer M; An LC
Ann Intern Med; 2014 Nov; 161(10 Suppl):S13-22. PubMed ID: 25402398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
